These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20720607)

  • 1. Sulphasalazine lung toxicity: report of two cases.
    Karmakar GC; Wong CA; Horwood F; Anderson G
    N Z Med J; 2010 Aug; 123(1320):86-7. PubMed ID: 20720607
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulphasalazine and lung toxicity.
    Parry SD; Barbatzas C; Peel ET; Barton JR
    Eur Respir J; 2002 Apr; 19(4):756-64. PubMed ID: 11999006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate-induced acute lung injury in a patient with rheumatoid arthritis.
    Taniguchi K; Usui Y; Matsuda T; Suzuki S; Fujiki K; Yakusiji F; Tomiyama J; Kinoshita K; Ilzuka H; Kuga Y
    Int J Clin Pharmacol Res; 2005; 25(3):101-5. PubMed ID: 16366417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DRESS syndrome induced by sulphasalazine in rheumatoid arthritis.
    Bejia I; Ben Hammouda S; Riahi K; Zinelabidine F; Mediouni B; Touzi M; Bergaoui N
    Joint Bone Spine; 2006 Dec; 73(6):764-5. PubMed ID: 16626997
    [No Abstract]   [Full Text] [Related]  

  • 5. Sulphasalazine-induced systemic lupus erythematosus in a patient with rheumatoid arthritis.
    Khattak FH; Morris IM; Mattingly PC
    Br J Rheumatol; 1996 Jan; 35(1):104. PubMed ID: 8624617
    [No Abstract]   [Full Text] [Related]  

  • 6. Facial Rash following Infliximab Treatment.
    Carmel NN; Levy Y
    J Rheumatol; 2016 Feb; 43(2):452. PubMed ID: 26834250
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphoma-like presentation in suspected rheumatoid arthritis due to sulphasalazine hypersensitivity syndrome.
    Shenoy P; Misra R; Jain M; Agarwal V
    N Z Med J; 2008 Jun; 121(1276):102-5. PubMed ID: 18574514
    [No Abstract]   [Full Text] [Related]  

  • 8. Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease.
    Borg AA
    Br J Rheumatol; 1995 Nov; 34(11):1097-8. PubMed ID: 8542218
    [No Abstract]   [Full Text] [Related]  

  • 9. [Severe drug hypersensitivity syndrome due to sulphasalazine in patient with rheumatoid arthritis].
    Gutierrez M; Filippucci E; Bugatti L; Bertolazzi C; Grassi W
    Reumatismo; 2009; 61(1):65-8. PubMed ID: 19370190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfasalazine induced lichen planus in a patient of rheumatoid arthritis.
    Ghosh S; Jain VK; Chaudhuri S; Mathur SK
    Indian J Dermatol Venereol Leprol; 2013; 79(4):541-4. PubMed ID: 23760333
    [No Abstract]   [Full Text] [Related]  

  • 11. Frequency of hospitalization and severe events in 497 spondylarthritis patients treated with anti-TNF drugs: comparisons with 423 RA patients.
    Gérard-Benoist S; Leux C; Le Goff B; Maugars Y; Berthelot JM
    Joint Bone Spine; 2012 Mar; 79(2):204-5. PubMed ID: 22088930
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporin for sulphasalazine-induced aplastic anaemia in a patient with early rheumatoid arthritis.
    Nurmohamed MT; Soesan M; van Oers MH; Dijkmans BA; van Soesbergen RM
    Rheumatology (Oxford); 2000 Dec; 39(12):1431-3. PubMed ID: 11136894
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug rash with eosinophilia and systemic symptoms syndrome induced by sulfasalazine.
    Bahat G; Celik HG; Tufan F; Saka B
    Joint Bone Spine; 2010 Jan; 77(1):87-8. PubMed ID: 19854669
    [No Abstract]   [Full Text] [Related]  

  • 14. Is the cure worse than the disease?
    Sacks R
    Aust Fam Physician; 2001 Jul; 30(7):679-80. PubMed ID: 11558203
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: Sulphasalazine-induced lung disease.
    Lancet; 1974 Aug; 2(7879):504-5. PubMed ID: 4136679
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospective study of the association between NAT2 gene haplotypes and severe adverse events with sulfasalazine therapy in patients with rheumatoid arthritis.
    Soejima M; Kawaguchi Y; Hara M; Kamatani N
    J Rheumatol; 2008 Apr; 35(4):724. PubMed ID: 18398952
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.
    Boers M; Verhoeven AC; Markusse HM; van de Laar MA; Westhovens R; van Denderen JC; van Zeben D; Dijkmans BA; Peeters AJ; Jacobs P; van den Brink HR; Schouten HJ; van der Heijde DM; Boonen A; van der Linden S
    Lancet; 1997 Aug; 350(9074):309-18. PubMed ID: 9251634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unusual cause for collapse in a patient with arthritis.
    Heath KJ; Sampson MJ; Ridley SA
    Intensive Care Med; 1996 Oct; 22(10):1096-7. PubMed ID: 8923077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse interaction between intramuscular methylprednisolone and sulphasalazine in patients with early rheumatoid arthritis. A pilot study.
    Gough A; Sheeran T; Arthur V; Panayi G; Emery P
    Scand J Rheumatol; 1994; 23(1):46-8. PubMed ID: 7906428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulphasalazine: a 'new' antirheumatic drug.
    Pullar T; Capell HA
    Br J Rheumatol; 1984 Feb; 23(1):26-34. PubMed ID: 6141832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.